Clinical Trial Update: Postnatal Enalapril to Improve Cardiovascular fUnction Following Preterm Pre-eclampsia [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating postnatal enalapril to improve cardiovascular function after preterm pre-eclampsia has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cardiovascular Diseases
• Pre-eclampsia

Drugs mentioned

• Enalapril (enalapril)

Snippet

Sponsor: Manchester University NHS Foundation Trust | Conditions: Cardiovascular Diseases, Pre-Eclampsia Onset Less Than 37 Weeks (Diagnosis) | Phase 2 | Status: COMPLETED